REVB: Revelation Biosciences Inc Kompaniya qiymatining sof foydaga nisbati
Revelation Biosciences (REVB) bioetik tamoyillar va chiqindilarni yo'q qilishning ekologik toza yondashuvini integratsiya qilish orqali respirator infeksiyalarni davolash vositalari ishlab chiqarishini kengaytirmoqda. Ushbu grafikning narx ko'rsatkichi P/E koeffitsiyenti -0.20 ekanligini ko'rsatmoqda. Biznes samaradorligi xodimlar xarajatlarini kamaytiradigan va yangi vaksinalarning ishlab chiqilishini tezlashtiradigan avtomatlashtirilgan sitokin tahlil tizimlari hisobiga oshirilmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_REVB_-_Revelation-Biosciences_-_PE-Multiple "REVB: Revelation Biosciences Biznesning o‘zini qoplash muddati 04.07.2022 - 13.11.2026 | 👁️GURU.Markets👁️")
Revelation Bio (REVB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Revelation Biosciences|REVB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Revelation Biosciences Corp|REVB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Revelation Biosciences, Inc.|REVB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Revelation Biosciences|Oraliq qoplash koeffitsiyenti revbiosciences.com
- foyda va bozor multiplikatorlari tafsilotlari:
REVB - Sof foyda|Kutilayotgan sof foyda Revelation Biosciences|REVB - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati Revelation Biosciences Inc|REVB - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Revelation Biosciences, Inc.|REVB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Revelation Biosciences|REVB - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi revbiosciences.com|REVB - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Revelation Biosciences
Kompaniyaning har tomonlama tahlili:revbiosciences.com REVB
Aktivlarni boshqaruvchilar emitentning adolatli qiymatini baholash uchun ob'ektiv asosga ehtiyoj sezadilar. P/E koeffitsiyenti bozor kapitalizatsiyasini sof foyda bilan solishtirib, foyda birligi uchun narxni aniqlaydi. Biznesning joriy P/E koeffitsiyenti tahlili baholashning davlat subsidiyalari va soliq rejimlariga qanchalik bog'liqligini ko'rsatadi. Revelation Biosciences (REVB) uchun ushbu ko'rsatkich ikkinchi darajali hisoblanadi, chunki biotexnologiya qiymati klinik sinovlarning muvaffaqiyati bilan belgilanadi. Bu metrikaning dinamikasi bu yerda shunchaki investorlarning yuqori xavfli aktivlarga bo'lgan ishtiyoqini aks ettiradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TRML (Tourmaline)|PGEN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narx-foyda koeffitsiyenti NKTR|Narxning foydaga nisbati UPB|P/E multiplikatori ZBIO|IMNM - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|kalvista.com - Narxning foydaga nisbati|Septerna - P/E multiplikatori|PVLA - P/E multiplikatori|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|RIGL: Bozor narxining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati enGene (ENGN)|RAPT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS: Narx-foyda multiplikatori|KYTX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|VTYX (Ventyx Biosciences Inc.) - Narxning foydaga nisbati|THTX (Theratechnologies Inc) - P/E multiplikatori|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Eledon Pharmaceuticals (ELDN)|AGEN - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Climb Bio CLYM|Biznesning o‘zini qoplash muddati Zura Bio Ltd (ZURA)|aTyr - P/E multiplikatori|Adagene (ADAG) - Narx-foyda koeffitsiyenti|IMA: P/E multiplikatori|STTK - Biznesning o‘zini qoplash muddati|EQ (Equillium Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Connect Pharma CNTB|Narxning foydaga nisbati Immunic, Inc. (IMUX)|atarabio.com - Narx-foyda multiplikatori|P/E multiplikatori IFRX (InflaRx)|XFOR - Narx-foyda koeffitsiyenti|Adicet - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Celularity Inc.|INmune Bio Corp (INMB) - Narxning foydaga nisbati|BRNS - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Kezar Life Sciences|SABS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AKTX|ENLV - Kapitalizatsiyaning foydaga nisbati|Q32 Bio - Narx-foyda koeffitsiyenti|GeoVax Corp - Narxning foydaga nisbati|Edesa Biotech, Inc. - P/E multiplikatori|IBIO: Narxning foydaga nisbati|carismatx.com (CARM) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati XTLB (XTL Biopharmaceuticals Ltd)|BOLT (Bolt Biotherapeutics Inc.) - P/E multiplikatori|HCWB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori APVO|P/E multiplikatori AIM ImmunoTech, Inc. (AIM)|Narxning foydaga nisbati Aditxt, Inc. ADTX|Kompaniya qiymatining sof foydaga nisbati GRI|XRTX - Narxning foydaga nisbati|Vyome Therapeutics (HIND) - Narx-foyda koeffitsiyenti|INDP: P/E multiplikatori|scinai.com (SCNI) - P/E multiplikatori|Narx-foyda koeffitsiyenti CALI|AFMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ALLK|Biznesning o‘zini qoplash muddati hookipapharma.com|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA - Narxning foydaga nisbati|TC BioPharm (Holdings) Plc (TCBP) - Narx-foyda koeffitsiyenti|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
